Lockheed’s Blowout Q2 and $230B Record Backlog: Why LMT Stock Isn’t a No-Brainer Buy

Posted on by

(SeaPRwire) –   By: Christian Pierce
Lockheed Martin just dropped one of its strongest quarterly reports in recent history. The stock jumped on the news Thursday, but barely moved in premarket trading Friday. It still sits 17% below its year-to-date high. That gap tells you everything about the current tension in defense equities. Investors stare at record order books and raised guidance, but hesitate to push the stock to new highs. They’re asking a simple question with no easy answer. How much of this quarter’s strength is already priced in, and how much is sustainable? No one doubts Lockheed’s dominance in its core markets. The question is whether that dominance translates to enough upside to justify a buy at current levels. Many retail investors see the headline beat and backlog number and assume it’s a clear buy. Wall Street’s consensus is only a “Moderate Buy,” with a target just 7% above Friday’s premarket price. That disconnect is the real story here, not the headline earnings beat.

Let’s walk through the hard numbers from the Q2 release. GAAP diluted EPS came in at $7.94, well above the $7.09 analyst consensus. Revenue hit $20.06 billion, up 11% year over year, and beat the $19.34 billion Wall Street estimate. The standout metric is the backlog. Lockheed ended Q2 with a record $230.4 billion in unfilled orders, up roughly $64 billion from a year ago. The book-to-bill ratio hit 3.2-to-1. That means it took in $3.20 in new orders for every $1 of revenue recognized. New orders for the quarter totaled $65 billion. Key wins included a $35 billion THAAD interceptor contract and a $3 billion GMLRS contract, among others. Free cash flow rebounded sharply to $2.9 billion in Q2. It recovered from prior-year program losses and supply chain disruptions that had weighed on the business. Management raised full-year EPS guidance to $29.95–$30.65, up from the previous range of $29.35–$30.25. That new range sits above the analyst consensus of $29.86. The company also lifted its 2026 revenue outlook to $79.75–$81.75 billion, up from $77.5–$80.0 billion. The Street had been expecting $79.14 billion for 2026. Operationally, the quarter brought resumed F-16 deliveries, increased C-130 production, and continued work on the Grizzly counter-drone system. Segment guidance tells a story of broad-based strength. Aeronautics is on track for $31.7–$32.7 billion in full-year sales. Mid-single-digit growth is expected in the second half, driven by higher F-35 production. Missiles and Fire Control is projected to hit $16.5–$16.9 billion. Acceleration is expected in the second half as munitions production ramps up. Rotary and Mission Systems is guided to $17.7–$18.1 billion. That growth is supported by radar programs and higher Sikorsky output. The Space segment’s outlook was raised to $13.85–$14.05 billion. Growth there is tied to the Next Generation Interceptor and Fleet Ballistic Missile programs. The stock closed Thursday up on the results, but premarket trading Friday had it flat at $568.60. Options data leans bullish, with a put-to-call ratio of 0.67x on January contracts. The upper strike price on those contracts sits near $645. That implies more than 14% upside over the next six months. Lockheed currently pays a dividend yield of 2.42%.

The commercial loop for defense primes like Lockheed is straightforward. Geopolitical tension drives government defense budgets. Those budgets flow into contract awards, which build backlog. Backlog converts to revenue and earnings over years. The current cycle is fueled by multiple overlapping conflicts and renewed NATO spending commitments. That’s why the backlog is at a record high. But investors know defense spending cycles don’t last forever. They also know backlog doesn’t always translate to expected profits. Program delays, cost overruns, and supply chain snags can erode margins on fixed-price contracts. Lockheed’s free cash flow recovery is a good sign, but it’s only one quarter of progress. It comes after years of supply chain headaches. The 17% gap to the year-to-date high reflects two key concerns. First, investors worry that peak defense spending may be near, even if budgets stay elevated for a few more years. Second, they’re pricing in the risk that production ramp-ups could hit unexpected snags. Those ramp-ups include F-35s and various munitions lines. The options market’s bullish tilt and Wall Street’s 7% upside target tell a muted story. No one is calling for a massive rally from here. For investors looking at LMT, the math is simple. You’re buying a dominant defense prime with a record backlog, a 2.42% dividend, and modest near-term upside. You’re not buying a high-growth stock that will double in a year. If you want a steady, defensive holding with predictable cash flow, it’s a reasonable pick. If you’re chasing quick gains from the headline beat, you’ll likely be disappointed. Stick to LMT if you want a core portfolio defense position. Skip it if you’re looking for explosive short-term returns.

Author bio: Christian Pierce, chief financial columnist and markets commentator with 15 years covering aerospace and defense equities.